As of April 16, 2025, Illumina (ILMN) has a market cap of $11.80 billion USD. According to our data, Illumina is ranked No.1403 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $11.80 B |
-44.30%
|
Dec 31, 2024 | $21.19 B |
-1.34%
|
Dec 29, 2023 | $21.48 B |
-31.14%
|
Dec 30, 2022 | $31.20 B |
-46.85%
|
Dec 31, 2021 | $58.69 B |
2.82%
|
Dec 31, 2020 | $57.08 B |
11.53%
|
Dec 31, 2019 | $51.18 B |
10.61%
|
Dec 31, 2018 | $46.27 B |
37.27%
|
Dec 29, 2017 | $33.71 B |
70.64%
|
Dec 30, 2016 | $19.75 B |
-33.30%
|
Dec 31, 2015 | $29.61 B |
3.99%
|
Dec 31, 2014 | $28.48 B |
66.90%
|
Dec 31, 2013 | $17.06 B |
98.94%
|
Dec 31, 2012 | $8.58 B |
82.38%
|
Dec 30, 2011 | $4.70 B |
-51.88%
|
Dec 31, 2010 | $9.77 B |
106.45%
|
Dec 31, 2009 | $4.73 B |
17.77%
|
Dec 31, 2008 | $4.02 B |
-12.08%
|
Dec 31, 2007 | $4.57 B |
50.75%
|
Dec 29, 2006 | $3.03 B |
178.79%
|
Dec 30, 2005 | $1.09 B |
48.73%
|
Dec 31, 2004 | $0.73 B |
34.47%
|
Dec 31, 2003 | $0.54 B |
109.20%
|
Dec 31, 2002 | $0.26 B |
-71.34%
|
Dec 31, 2001 | $0.91 B |
-26.79%
|
Dec 29, 2000 | $1.24 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
![]() USA
|
![]() Agilent Technologies
A
|
$29.40 B |
-0.001 M
|
![]() USA
|
![]() Pacific Biosciences
PACB
|
$0.38 B |
-0.000 M
|
![]() USA
|
![]() Qiagen
QGEN
|
$8.98 B |
0.000 M
|
![]() Netherlands
|
![]() Bionano Genomics
BNGO
|
$13.44 M |
0.000 M
|
![]() USA
|
![]() Bio-Rad Laboratories
BIO
|
$6.82 B |
1.204 B
|
![]() USA
|
![]() Danaher
DHR
|
$135.88 B |
0.003 M
|
![]() USA
|
![]() 10x Genomics
TXG
|
$1.00 B |
0.115 B
|
![]() USA
|
![]() Guardant Health
GH
|
$5.54 B |
0.000 M
|
![]() USA
|
![]() Myriad Genetics
MYGN
|
$0.74 B |
-0.000 M
|
![]() USA
|
Market Cap | = | ILMN Stock Price | * | ILMN Shares Outstanding |
= | $74.59 | * | 0.16 B | |
= | $11.80 B |